HSP90AA1 and cancer: Many of the proteins controlled by HSP90 are implicated in important cellular processes and HSP90 itself is often dysregulated in cancer cells; therefore, it is considered a potential biomarker and therapeutic target in cancer, against which different inhibitors are being developed [9,10,11].